Use access key #2 to skip to page content.
$2.10 0.00 (0.00%)
5/2/2008 4:00 PM

Renovis, Inc. (RNVS)

CAPS Rating:
*

The Company is a science-driven, biopharmaceutical company that seeks to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases.

View All Commentary (RNVS)

Recs

0

Avatar maverickpl (99.89) Submitted: 4/10/07 1:17 PM : Outperform Start Price: $4.55 RNVS Score: -25.09

I really don't know much about biotech besides the whole thing is a crap shoot. I keep wanting to make underperform calls on these stocks because most of them fail. Having said that, perhaps one of them will go through the roof, and it really can't hurt my score too much as an outperform. I could have picked any 4 letters, but I'm going with RNVS.

Report this Post Replies: 0 | Reply

Featured Broker Partners